Short-course Regimens for the Treatment of Pulmonary Tuberculosis
Conditions:   Tuberculosis, Pulmonary;   Tuberculosis Infection Interventions:   Drug: Rifabutin;   Drug: Delamanid;   Drug: Bedaquiline;   Drug: Moxifloxacin;   Drug: Pyrazinamide;   Drug: Isoniazid;   Drug: Rifampin;   Drug: Ethambutol Sponsors:   Centers for Disease Control and Prevention;   Tuberculosis Trials Consortium Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2023 Category: Research Source Type: clinical trials